Showing results (51-60 of 1,102) with videos related to
Sort By:
Pageof 111
Current Drug Targets|August 12, 2009
Anti-EGFR therapy in colorectal cancer: how to choose the right patientF Meriggi, B Di Biasi, C Abeni, et al.Phytopathology|October 24, 2008
Molecular Variability Among Isolates of Prunus Necrotic Ringspot Virus from Different Prunus sppF Aparicio, A Myrta, B Di Terlizzi, et al.Veterinaria Italiana|April 30, 2010
A study of the shelf-life of critical culture mediaS Ulisse, A Peccio, G Orsini, et al.Annali Di Chimica|January 5, 2002
New possible chelating agents of clinical interest for iron(III): 2-hydroxynicotinic acid and 3-hydroxypicolinic acid. A thermodynamic studyV B Di Marco, A Tapparo, G G BombiRespiration; International Review of Thoracic Diseases|January 1, 1984
Ventilatory volumes, flow rates, transfer factor and its components (membrane component, capillary volume) in obese adults and childrenE Bosisio, M Sergi, B di Natale, et al.Chemotherapy|December 8, 2007
The potential role of pemetrexed in gastrointestinal cancerF Meriggi, B Di Biasi, C Caliolo, et al.Reviews on Recent Clinical Trials|December 24, 2009
The use of bevacizumab and trastuzumab beyond tumor progression: a new avenue in cancer treatment?F Meriggi, C Abeni, B Di Biasi, et al.International Journal of Oral and Maxillofacial Surgery|July 19, 2020
Early implant placement and peri-implant augmentation with a porcine-derived acellular dermal matrix and synthetic bone in the aesthetic area: a 2-year follow-up prospective cohort studyP Papi, N Pranno, B Di Murro, et al.Parassitologia|August 1, 1989
Sarcocystis in Somali camelA Borrow Hagi, A Mohammed Hassan, B di SaccoScientific Reports|November 24, 2017
The directed evolution of ligand specificity in a GPCR and the unequal contributions of efficacy and affinityRaphaël B Di Roberto, Belinda Chang, Sergio G PeisajovichPageof 111